Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CD166 Polyclonal Antibody
Goat Polyclonal Antibody
Supplier: Invitrogen™ PA547083
Description
In direct ELISAs, approximately 40% cross-reactivity with recombinant human (rh) ALCAM is observed, and less than 10% cross-reactivity with rhBCAM, recombinant mouse (rm) OCAM, and rmMAdCAM-1 is observed. Reconstitute at 0.2 mg/mL in sterile PBS.
This gene encodes activated leukocyte cell adhesion molecule (ALCAM), also known as CD166 (cluster of differentiation 166), which is a member of a subfamily of immunoglobulin receptors with five immunoglobulin-like domains (VVC2C2C2) in the extracellular domain. This protein binds to T-cell differentiation antigene CD6, and is implicated in the processes of cell adhesion and migration. Multiple alternatively spliced transcript variants encoding different isoforms have been found.
Specifications
CD166 | |
Polyclonal | |
Unconjugated | |
ALCAM | |
activated leukocyte cell adhesion molecule; AI853494; ALCAM; BEN; CD166; CD166 antigen; cell adhesion molecule; DM-GRASP; FLJ38514; HB2; KG-CAM; MEMD; MGC71733; MuSC; Protein DM-GRASP; Protein MEMD; SB-10 antigen; SC1; unnamed protein product | |
Goat | |
Antigen Affinity Chromatography | |
RUO | |
11658, 214, 478550, 79559 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Lyophilized |
Flow Cytometry, Immunohistochemistry (Frozen), Western Blot, Immunocytochemistry | |
0.2 mg/mL | |
PBS with 5% trehalose and No Preservative | |
O35112, O46634, Q13740, Q61490 | |
ALCAM | |
Mouse myeloma cell line NS0-derived recombinant mouse ALCAM/CD166 Trp28-Lys527. | |
100 μg | |
Primary | |
Human, Mouse, Rat, Canine | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction